Biohaven Pharmaceutical Holding Co Ltd (BHVN) — Long-term Investment Intensity
Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a Long-term Investment Intensity of 7.4% as of September 2022. Long-term investments of $10.00 Million represent 7.4% of total assets of $135.65 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Biohaven Pharmaceutical Holding Co Ltd cash conversion from operations to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biohaven Pharmaceutical Holding Co Ltd Long-term Investment Intensity (2020–2021)
This chart shows how Biohaven Pharmaceutical Holding Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the intensity stands at 7.4%, reflecting long-term investments of $10.00 Million against total assets of $135.65 Million USD. Explore debt repayment capacity of Biohaven Pharmaceutical Holding Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Biohaven Pharmaceutical Holding Co Ltd (2020–2021)
The table below presents the year-by-year Long-term Investment Intensity for Biohaven Pharmaceutical Holding Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BHVN stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 4.2% | $6.00 Million | $142.06 Million | ▼ -2.2 pp |
| 2020 | 6.4% | $7.18 Million | $111.50 Million | — |